Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 3
2006 2
2007 4
2008 5
2009 4
2010 4
2011 4
2012 2
2013 9
2014 11
2015 4
2016 8
2017 7
2018 7
2019 9
2020 8
2021 5
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
[MAIT lymphocytes: A new therapeutic target in liver fibrosis].
Mabire M, Gilgenkrantz H, Lotersztajn S. Mabire M, et al. Among authors: lotersztajn s. Med Sci (Paris). 2023 Aug-Sep;39(8-9):591-593. doi: 10.1051/medsci/2023087. Epub 2023 Sep 11. Med Sci (Paris). 2023. PMID: 37695142 French. No abstract available.
Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration.
Allaire M, Al Sayegh R, Mabire M, Hammoutene A, Siebert M, Caër C, Cadoux M, Wan J, Habib A, Le Gall M, de la Grange P, Guillou H, Postic C, Paradis V, Lotersztajn S, Gilgenkrantz H. Allaire M, et al. Among authors: lotersztajn s. JHEP Rep. 2023 May 16;5(8):100794. doi: 10.1016/j.jhepr.2023.100794. eCollection 2023 Aug. JHEP Rep. 2023. PMID: 37520673 Free PMC article.
MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming.
Mabire M, Hegde P, Hammoutene A, Wan J, Caër C, Sayegh RA, Cadoux M, Allaire M, Weiss E, Thibault-Sogorb T, Lantz O, Goodhardt M, Paradis V, de la Grange P, Gilgenkrantz H, Lotersztajn S. Mabire M, et al. Among authors: lotersztajn s. Nat Commun. 2023 Apr 1;14(1):1830. doi: 10.1038/s41467-023-37453-5. Nat Commun. 2023. PMID: 37005415 Free PMC article.
Inflammation in alcohol-associated liver disease progression.
Lotersztajn S, Riva A, Wang S, Dooley S, Chokshi S, Gao B. Lotersztajn S, et al. Z Gastroenterol. 2022 Jan;60(1):58-66. doi: 10.1055/a-1714-9246. Epub 2022 Jan 18. Z Gastroenterol. 2022. PMID: 35042254 English.
Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target.
Smati S, Polizzi A, Fougerat A, Ellero-Simatos S, Blum Y, Lippi Y, Régnier M, Laroyenne A, Huillet M, Arif M, Zhang C, Lasserre F, Marrot A, Al Saati T, Wan J, Sommer C, Naylies C, Batut A, Lukowicz C, Fougeray T, Tramunt B, Dubot P, Smith L, Bertrand-Michel J, Hennuyer N, Pradere JP, Staels B, Burcelin R, Lenfant F, Arnal JF, Levade T, Gamet-Payrastre L, Lagarrigue S, Loiseau N, Lotersztajn S, Postic C, Wahli W, Bureau C, Guillaume M, Mardinoglu A, Montagner A, Gourdy P, Guillou H. Smati S, et al. Among authors: lotersztajn s. Gut. 2022 Apr;71(4):807-821. doi: 10.1136/gutjnl-2020-323323. Epub 2021 Apr 26. Gut. 2022. PMID: 33903148 Free article.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R… See abstract for full author list ➔ Klionsky DJ, et al. Among authors: lotersztajn s. Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8. Autophagy. 2021. PMID: 33634751 Free PMC article.
Targeting cell-intrinsic metabolism for antifibrotic therapy.
Gilgenkrantz H, Mallat A, Moreau R, Lotersztajn S. Gilgenkrantz H, et al. Among authors: lotersztajn s. J Hepatol. 2021 Jun;74(6):1442-1454. doi: 10.1016/j.jhep.2021.02.012. Epub 2021 Feb 22. J Hepatol. 2021. PMID: 33631228 Review.
Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF.
Weiss E, de la Grange P, Defaye M, Lozano JJ, Aguilar F, Hegde P, Jolly A, Moga L, Sukriti S, Agarwal B, Gurm H, Tanguy M, Poisson J, Clària J, Abback PS, Périanin A, Mehta G, Jalan R, Francoz C, Rautou PE, Lotersztajn S, Arroyo V, Durand F, Moreau R. Weiss E, et al. Among authors: lotersztajn s. Front Immunol. 2021 Feb 5;11:619039. doi: 10.3389/fimmu.2020.619039. eCollection 2020. Front Immunol. 2021. PMID: 33613548 Free PMC article.
87 results